Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Response of men with advanced prostatic carcinoma to exogenous administration of testosterone.

× No keyword cloud information.

36 in total

Review 1. Differing levels of testosterone and the prostate: a physiological interplay.

Authors: S Larry Goldenberg; Anthony Koupparis; Michael E Robinson
Journal: Nat Rev Urol Date: 2011-05-31 Impact factor: 14.432

2. Addressing the pressing issues related to testosterone administration to men with prostate cancer.

Authors: Alvaro Morales
Journal: Can Urol Assoc J Date: 2016 May-Jun Impact factor: 1.862

Review 3. Hormonal aspects of prostatic cancer: a review.

Authors: J Waxman
Journal: J R Soc Med Date: 1985-02 Impact factor: 5.344

4. Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study.

Authors: Michael T Schweizer; Emmanuel S Antonarakis; Hao Wang; A Seun Ajiboye; Avery Spitz; Haiyi Cao; Jun Luo; Michael C Haffner; Srinivasan Yegnasubramanian; Michael A Carducci; Mario A Eisenberger; John T Isaacs; Samuel R Denmeade
Journal: Sci Transl Med Date: 2015-01-07 Impact factor: 17.956

5. DHX15 is up-regulated in castration-resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations.

Authors: Yadong Xu; Qiong Song; Laura E Pascal; Mingming Zhong; Yibin Zhou; Jianhua Zhou; Fang-Ming Deng; Jiaoti Huang; Zhou Wang
Journal: Prostate Date: 2019-02-03 Impact factor: 4.104

Review 6. The Role of Testosterone in the Treatment of Castration-Resistant Prostate Cancer.

Authors: Michael W Drazer; Walter M Stadler
Journal: Cancer J Date: 2016 Sep/Oct Impact factor: 3.360

7. Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer.

Authors: Takeshi Hashimoto; Krishnan Rahul; Toshikazu Takeda; Nicole Benfante; John P Mulhall; Hedvig Hricak; James A Eastham; Hebert Alberto Vargas
Journal: Urol Oncol Date: 2016-09-22 Impact factor: 3.498

8. A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.

Authors: Russell Szmulewitz; Supriya Mohile; Edwin Posadas; Rangesh Kunnavakkam; Theodore Karrison; Elizabeth Manchen; Walter M Stadler
Journal: Eur Urol Date: 2009-02-27 Impact factor: 20.096

Review 9. Current status of the management of patients with endocrine-sensitive tumors. II. Carcinoma of the prostate, endometrium, thyroid, kidney and miscellaneous tumors.

Authors: L G Crowley; S A Duwe
Journal: Calif Med Date: 1969-02

10. Analysis of changes in rat prostate carcinoma following hormone deprivation.

Authors: W C Beckman; A L Jacokes; J L Camps; R L Cook; G P Siegal
Journal: Am J Pathol Date: 1987-09 Impact factor: 4.307